U.S. Asana, GE Vernova, New Gold
June 3 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Asana, GE Vernova and New Gold, on Monday.
HIGHLIGHTS
* Asana ASAN.N: HSBC raises to hold from reduce |
* GE Vernova Inc GEV.N: JP Morgan raises target price to $186 from $176 |
* New Gold Inc NGD.N: CIBC raises to outperformer from neutral |
* Owens Corning OC.N: Barclays raises target price to $190 from $160 |
* Radian Group Inc RDN.N: KBW raises to outperform from market perform |
Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.
* 10X Genomics Inc TXG.O: Jefferies initiates coverage with hold rating; PT $24 |
* Advanced Energy Industries AEIS.O: BofA Global Research raises PT to $120 from $102 |
* Advanced Micro Devices Inc AMD.O: BofA Global Research raises PT to $195 from $185 |
* Agilent Technologies Inc A.N: Jefferies assumes coverage with hold vs buy rating |
* Agilent Technologies Inc A.N: Jefferies assumes coverage with PT $135 vs $152 |
* American Airlines AAL.O: Morgan Stanley cuts target price to $18 from $20 |
* Apple Hospitality REIT APLE.N: Wedbush initiates coverage with neutral rating and $15 PT |
* Arcus Biosciences Inc RCUS.N: Citigroup raises target price to $38 from $36 |
* Asana ASAN.N: HSBC cuts target price to $14 from $16 |
* Asana ASAN.N: HSBC raises to hold from reduce |
* Autodesk Inc ADSK.O: BofA Global Research cuts price objective to $260 from $300 |
* Avalonbay Communities Inc AVB.N: BMO raises target price to $205 from $200 |
* Axcelis Technologies Inc ACLS.O: BofA Global Research raises PT to $125 from $115 |
* Backblaze Inc BLZE.O: Craig-Hallum assumes coverage With Buy rating; PT $9 |
* Best buy Co Inc BBY.N: Citigroup raises to buy from sell; raises PT to $100 from $67 |
* Best buy Co Inc BBY.N: Guggenheim raises target price to $90 from $86 |
* Bio Rad Laboratories Inc BIO.N: Jefferies assumes coverage with hold vs buy rating |
* Bio Rad Laboratories Inc BIO.N: Jefferies assumes coverage with PT $315 vs $440 |
* Biolase Inc BIOL.O: Ascendiant Capital Markets cuts target price to $3.5 from $4 |
* Boeing BA.N: Bernstein cuts target price to $215 from $230 |
* Boston Properties Inc BXP.N: BMO cuts target price to $75 from $78 |
* Braze Inc BRZE.O: Scotiabank cuts target price to $48 from $58 |
* Broadcom Inc AVGO.O: Melius Research initiates coverage with buy rating; PT $1850 |
* Camden Property Trust CPT.N: BMO raises target price to $105 from $100 |
* Caredx Inc CDNA.O: Jefferies assumes coverage with buy rating; PT $17 vs $12 |
* Caribou Biosciences Inc CRBU.O: Evercore ISI cuts target price to $3 from $13 |
* Caribou Biosciences Inc CRBU.O: Evercore ISI cuts to in line from outperform |
* Centene Corp CNC.N: Stephens cuts target price to $77 from $83 |
* Centerspace CSR.N: BMO raises target price to $69 from $59 |
* Chord Energy Corp CHRD.O: BMO raises target price to $230 from $180 |
* Chord Energy Corp CHRD.O: Truist Securities cuts target price to $226 from $228 |
* Conocophillips COP.N: Truist Securities raises target price to $165 from $160 |
* Corbus Pharmaceuticals Holdings Inc CRBP.O: Oppenheimer raises PT to $80 from $60 |
* Digital Realty Trust Inc DLR.N: RBC raises target price to $160 from $144 |
* Dolby Laboratories Inc DLB.N: Barrington Research raises to outperform |
* Elastic NV ESTC.N: Citigroup raises target price to $155 from $145 |
* Enact Holdings Inc ACT.O: KBW raises target price to $38 from $37 |
* Equity Residential EQR.N: BMO raises target price to $71 from $70 |
* Essex Property Trust Inc ESS.N: BMO raises target price to $265 from $244 |
* Factset Research Systems Inc FDS.N: Morgan Stanley cuts PT to $350 from $372 |
* FirstEnergy Corp FE.N: Mizuho raises target price to $41 from $38 |
* Gap Inc GPS.N: TD Cowen raises target price to $28 from $24 |
* GE Vernova Inc GEV.N: JP Morgan raises target price to $186 from $176 |
* Genasys Inc GNSS.O: Ascendiant Capital Markets cuts target price to $4.25 from $4.75 |
* Genesco Inc GCO.N: Jefferies raises target price to $29 from $25 |
* Glaukos Corp GKOS.N: Wells Fargo raises target price to $120 from $110 |
* Guardant Health Inc GH.O: Jefferies initiates coverage with buy rating; PT $32 |
* Hilton Grand Vacations Inc HGV.N: Deutsche Bank raises target price to $56 from $53 |
* Hims & Hers Health Inc HIMS.N: BofA Global Research raises PT to $22 from $17.25 |
* Hudson Pacific Properties Inc HPP.N: BMO cuts target price to $8 from $11 |
* Iheartmedia Inc IHRT.O: BofA Global Research cuts price objective to $1 from $1.7 |
* Illumina Inc ILMN.O: Jefferies initiates coverage with hold rating; PT $115 |
* Imac Holdings Inc BACK.O: Ascendiant Capital Markets raises target to $8.25 from $8 |
* Immunovant Inc IMVT.O: Oppenheimer cuts target price to $46 from $50 |
* Independence Realty Trust Inc IRT.N: BMO raises target price to $16 from $15 |
* Inspire Medical Systems Inc INSP.N: BofA Global Research cuts PT to $185 from $225 |
* Intrusion Inc INTZ.O: Ascendiant Capital Markets cuts target price to $16 from $20 |
* Invitation Homes Inc INVH.N: Mizuho cuts target price to $36 from $37 |
* Kimberly-Clark Corp KMB.N: RBC raises target price to $165 from $126 |
* Kimberly-Clark Corp KMB.N: RBC raises to outperform from sector perform |
* Kla Corp KLAC.O: BofA Global Research raises price objective to $890 from $850 |
* Knightscope Inc KSCP.O: Ascendiant Capital Markets cuts PT to $3.75 from $4.25 |
* Kratos Defense and Security Solutions Inc KTOS.O: RBC raises target to $24 from $23 |
* Krispy Kreme Inc DNUT.O: JP Morgan assumes coverage with overweight vs neutral rating |
* Lam Research Corp LRCX.O: BofA Global Research raises PT to $1100 from $1000 |
* Life Time Group Holdings Inc LTH.N: Guggenheim raises target price to $22 from $20 |
* Lithia Motors Inc LAD.N: Evercore ISI cuts target price to $360 from $400 |
* M&T Bank Corp MTB.N: Jefferies raises target price to $160 from $151 |
* Magnite Inc MGNI.O: Evercore ISI raises target price to $15 from $13 |
* Marathon Oil Corp MRO.N: Citigroup cuts to neutral from buy; cuts PT to $29 from $32 |
* Marriott Vacations Worldwide Corp VAC.N: JP Morgan cuts PT to $108 from $116 |
* Marvell Technology Inc MRVL.O: BofA Global Research cuts PT to $85 from $95 |
* Mesa Laboratories Inc MLAB.O: Jefferies assumes coverage with buy rating; PT $130 |
* Methanex Corp MEOH.O: RBC raises target price to $55 from $50 |
* Mettler-Toledo International MTD.N: Jefferies assumes with PT $1250 vs $1230 |
* Mettler-Toledo International MTD.N: Jefferies assumes with underperform vs hold rating |
* Mgic Investment Corp MTG.N: KBW raises target price to $25 from $24 |
* Mgic Investment Corp MTG.N: KBW raises to outperform from market perform |
* Microchip Technology Inc MCHP.O: BofA Global Research raises PT to $110 from $100 |
* Mid-America Apartment Communities Inc MAA.N: BMO raises PT to $133 from $128 |
* Moderna MRNA.O: Leerink Partners raises target price to $62 from $60 |
* Moderna MRNA.O: RBC raises target price to $160 from $135 |
* Mongodb Inc MDB.O: Bernstein cuts target price to $358 from $491 |
* Mongodb Inc MDB.O: Citigroup cuts target price to $350 from $480 |
* Mongodb Inc MDB.O: Guggenheim raises to neutral from sell |
* Motorola Solutions Inc MSI.N: Deutsche Bank raises target price to $385 from $375 |
* Murphy USA Inc MUSA.N: JP Morgan cuts target price to $415 from $418 |
* Myriad Genetics MYGN.O: Jefferies assumes coverage with price target $20 vs $25 |
* Myriad Genetics MYGN.O: Jefferies assumes coverage with underperform vs hold rating |
* Natera Inc NTRA.O: Jefferies initiates coverage with buy rating; price target $142 |
* Nautilus Biotechnology Inc NAUT.O: Jefferies assumes coverage with hold vs buy rating |
* Nautilus Biotechnology Inc NAUT.O: Jefferies assumes coverage with target $3 vs $5 |
* New Gold Inc NGD.N: CIBC raises target price to $3 from $2.1 |
* New Gold Inc NGD.N: CIBC raises to outperformer from neutral |
* NMI Holdings Inc NMIH.O: KBW raises target price to $37 from $36 |
* Nvidia Corp NVDA.O: BofA Global Research raises price objective to $1500 from $1320 |
* Okta Inc OKTA.O: BMO cuts target price to $100 from $110 |
* Owens Corning OC.N: Barclays raises target price to $190 from $160 |
* Owens Corning Inc. OC.N: Barclays raises target price to $190 from $160 |
* Pacific Biosciences of California Inc PACB.O: Jefferies initiates with buy rating |
* Pacific Biosciences of California Inc PACB.O: Jefferies initiates with PT $4 |
* Perma-Fix Environmental Services PESI.O: Craig-Hallum initiates coverage with buy rating; PT $18 |
* Phreesia Inc PHR.N: Truist Securities cuts target price to $29 from $35 |
* Plus Therapeutics Inc PSTV.O: Ascendiant Capital Markets cuts target to $21 from $22 |
* Proficient Auto Logistics PAL.O: Raymond James initiates coverage with outperform rating; PT $18 |
* Proficient Auto Logistics PAL.O: Stifel initiates coverage with buy rating; PT $19 |
* Proficient Auto Logistics PAL.O: William Blair initiates coverage with outperform rating |
* PVH Corp PVH.N: Evercore ISI raises target price to $140 from $130 |
* PVH Corp PVH.N: TD Cowen raises target price to $153 from $145 |
* Radian Group Inc RDN.N: KBW raises target price to $36 from $35 |
* Radian Group Inc RDN.N: KBW raises to outperform from market perform |
* Rexford Industrial Realty Inc REXR.N: BMO raises target price to $48 from $47 |
* Sentinelone Inc S.N: Needham cuts target price to $25 from $31 |
* Sentinelone Inc S.N: Wedbush cuts target price to $20 from $32 |
* Silvaco Group Inc SVCO.O: Jefferies initiates coverage with buy rating; PT $25 |
* Silvaco Group Inc SVCO.O: Needham initiates coverage with buy rating and $28 PT |
* Silvaco Group Inc SVCO.O: TD Cowen initiates coverage with buy rating; PT $23 |
* Sintx Technologies Inc SINT.O: Ascendiant Capital Markets cuts PT to $70 from $300 |
* Soho House & Co Inc SHCO.N: Citigroup cuts target price to $8 from $10 |
* Sow Good Inc SOWG.O: Craig-Hallum raises target price to $25 from $20 |
* Sprout Social Inc SPT.O: Jefferies cuts target price to $42 from $76 |
* Summit Therapeutics Inc SMMT.O: Citigroup raises target price to $13 from $7 |
* Summit Therapeutics Inc SMMT.O: Stifel raises target price to $14 from $8 |
* Teladoc Health Inc TDOC.N: Jefferies cuts target price to $10 from $14 |
* Teradyne Inc TER.O: BofA Global Research raises price objective to $126 from $105 |
* Texas Instruments Inc TXN.O: BofA Global Research raises PT to $220 from $190 |
* the Gap, Inc. GPS.N: Barclays raises target price to $31 from $28 |
* Thermo Fisher Scientific TMO.N: Jefferies assumes coverage with buy vs hold rating |
* Thermo Fisher Scientific TMO.N: Jefferies assumes coverage with PT $650 vs $600 |
* TJX Companies Inc TJX.N: BMO raises target price to $116 from $110 |
* Uipath Inc PATH.N: BMO cuts target price to $14 from $28 |
* Ulta Beauty, Inc. ULTA.O: Barclays cuts target price to $394 from $434 |
* Ultragenyx Pharmaceutical Inc RARE.O: Barclays raises PT to $83 from $81 |
* Veeva Systems Inc VEEV.N: Citigroup cuts target price to $256 from $274 |
* Veeva Systems Inc VEEV.N: Jefferies cuts target price to $225 from $270 |
* Ventas Inc VTR.N: Deutsche Bank cuts target price to $55 from $60 |
* Ventas Inc VTR.N: Raymond James raises target price to $50.26 from $50 |
* Viking Holdings Ltd VIK.N: Morgan Stanley raises target price to $33 from $31 |
* Walgreens WBA.O: Evercore ISI cuts target price to $17 from $18 |
* Walmart WMT.N: Evercore ISI raises target price to $72 from $70 |
* Welltower Inc WELL.N: Raymond James raises target price to $120 from $110 |
(Compiled by Bengaluru Newsroom)
</body></html>Související aktiva
Poslední novinky
Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.
Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.
Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.
